CAS 126239-77-8

b-D-Glucopyranoside,(2R)-3-hydroxy-2-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]propyl (9CI)

Description:

The chemical substance known as b-D-Glucopyranoside, (2R)-3-hydroxy-2-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]propyl, with the CAS number 126239-77-8, is a glycoside compound characterized by its glucopyranoside structure, which consists of a glucose unit linked to a phenolic compound. This substance features a hydroxyl group and a propenyl moiety, contributing to its potential biological activity. The presence of the 4-hydroxyphenyl group suggests that it may exhibit antioxidant properties, while the glucopyranoside structure can enhance solubility and bioavailability. The compound is likely to be soluble in polar solvents due to its hydroxyl groups, and it may participate in various biochemical interactions, making it of interest in fields such as pharmacology and biochemistry. Its specific applications and effects would depend on further studies, particularly in relation to its interaction with biological systems and potential therapeutic uses.

Formula: C₁₈H₂₄O₁₀

Synonyms:

• b-D-Glucopyranoside,3-hydroxy-2-[[3-(4-hydroxyphenyl)-1-oxo-2-propenyl]oxy]propyl, [R-(E)]-
• Regaloside H
• 3-(4-Hydroxyphenyl)propenoic acid (2R)-1-(β-D-glucopyranosyloxy)-3-hydroxypropan-2-yl ester
• β-D-Glucopyranoside, (2R)-3-hydroxy-2-[[(2E)-3-(4-hydroxyphenyl)-1-oxo-2-propen-1-yl]oxy]propyl

Regaloside H

CAS: 126239-77-8

Regaloside H

Purity: ≥98%

Molecular weight: 400.38g/mol

Ref: 54-BUP01766

Regaloside H

CAS: 126239-77-8

Formula: C₁₈H₂₄O₁₀

Purity: 95%~99%

Molecular weight: 400.38

Ref: BP-BP4538

Regaloside H

CAS: 126239-77-8

Regaloside H, a glyceryl phenylpropionate glycoside, is a gluconeogenesis inhibitor.

Formula: C₁₈H₂₄O₁₀

Purity: 99.94% - 99.94%

Color and Shape: Solid

Molecular weight: 400.38

Ref: TM-TN7038

Regaloside H

CAS: 126239-77-8

Regaloside H is a medicinal compound found in urine that has shown promising results in the treatment of cancer. It works by inducing apoptosis, or programmed cell death, in cancer cells. Regaloside H has been shown to inhibit kinase activity, which is involved in cell cycle regulation and proliferation. This inhibitor effect makes it a potential candidate for anticancer therapy. In Chinese medicine, Regaloside H has been used as an herbal remedy for treating tumors. Studies have shown that it can target specific kinases that are overexpressed in certain types of human cancers, making it a potentially effective treatment option for cancer patients. Overall, Regaloside H represents a promising new avenue for the development of novel anticancer therapies.

Formula: C₁₈H₂₄O₁₀

Purity: Min. 95%

Molecular weight: 400.4 g/mol

Ref: 3D-BFA23977